HALO logo
halo search icon
Aprea Therapeutics, Inc.

US$0.90

Price Change Indicator
0.10 (12.49%)
Aprea Therapeutics, Inc.
APRE · NAS

Aprea Therapeutics, Inc.

Start Trading APRE for Free

US$0.90

Price Arrow0.10 (12.49%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusEngulfing BullishHALO AllHALO Consensus ValueHALO Earnings MomentumHALO Growth
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Aprea Therapeutics, Inc. Overview

APRE Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About APRE

icon
icon

Telephone

1.617.463.9385

icon

Address

3805 Old Easton Road, Doylestown, PA 18902

Description

Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of cancer therapeutics. It is involved in the development and commercialization of novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wen Jie Bao in 2002 and is headquartered in Doylestown, PA.

APRE Price Chart

Key Stats

Market Cap

US$9.91M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.55 - 2.22

Trade Value (12mth)

US$133,421.00

1 week

-13.99%

1 month

-11.83%

YTD

-6.21%

1 year

-50%

All time high

1062.20

Key Fundamentals

EPS 3 yr Growth

-99.90%

EBITDA Margin

NaN%

Operating Cashflow

-$13m

Free Cash Flow Return

-76.30%

ROIC

-74.60%

Interest Coverage

0.00

Quick Ratio

5.60

Other Data

Shares Outstanding (Fully Diluted)

15m

HALO Sector

Healthcare

Next Company Report Date

30-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

APRE Announcements

Latest Announcements

DateAnnouncements
13 May 26
13 May 26
13 May 26
13 May 26
13 May 26

APRE Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-3.95-2.35-1.93locklocklock
EPS (Fully Diluted)
 $locklocklocklock-3.95-2.35-1.93locklocklock
Growth
 %locklocklocklock99.740.418.1locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Aprea Therapeutics, Inc. (APRE:NAS)?
Halo FAQ
The current share price of Aprea Therapeutics, Inc. (APRE:NAS) is USD$0.90.
What is the 52-week high share price for Aprea Therapeutics, Inc. (APRE:NAS)?
Halo FAQ
The 52-week high share price for Aprea Therapeutics, Inc. (APRE:NAS) is USD$2.22.
What is the 52-week low share price for Aprea Therapeutics, Inc. (APRE:NAS)?
Halo FAQ
The 52-week low share price for Aprea Therapeutics, Inc. (APRE:NAS) is USD$0.55.
What is the dividend yield for Aprea Therapeutics, Inc. (APRE:NAS)?
Halo FAQ
Aprea Therapeutics, Inc. (APRE:NAS) does not pay a dividend.
What was Aprea Therapeutics, Inc. (APRE:NAS) last dividend payment?
Halo FAQ
Aprea Therapeutics, Inc. (APRE:NAS) does not pay a dividend.
What is the franking level for Aprea Therapeutics, Inc. (APRE:NAS)?
Halo FAQ
Aprea Therapeutics, Inc. (APRE:NAS) has a franking level of 0.00%.
In which sector is Aprea Therapeutics, Inc. (APRE:NAS) classified?
Halo FAQ
Aprea Therapeutics, Inc. (APRE:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial